Dashboard
Financial statements
BAX

Company financials

Baxter International

Health Care Health Care Equipment Deerfield, Illinois Last filing Feb 12, 2026 · FY2025
Revenue FY2025
$11.2B
3y CAGR +3.8% P42
Net income FY2025
$-957.0M
Net margin -8.5% P5
Total assets FY2025
$20.1B
ROA -4.8% P7
Operating cash flow FY2025
$845.0M
19 yrs · FY2007–FY2025 9 filed · 0 derived · 0 blank

Year-over-year change per cell; first column has no prior.

Balance Sheet

Assets, liabilities, and equity

29 accounts · 3 years
Total assets $20.1B
Total liabilities $14.0B
Shareholders equity $6.1B
Account 2025 2024 2023 Trend
Assets
Cash and Cash Equivalents +11.5% -42.7%
Short Term Investments
Accounts Receivable +10.8% -37.6%
Inventory +9.1% -27.5%
Prepaid Expenses +8.0% -15.6%
Total Current Assets -22.4% -7.8%
Property,Plant and Equipment +1.4% -35.3%
Operating Lease Assets -9.8% -41.6%
Goodwill -6.6% -19.0%
Intangible Assets -16.4% -14.1%
Other Noncurrent Assets -7.4% -32.9%
Total Assets -22.2% -8.8%
Liabilities
Accounts Payable +3.2% -22.0%
Accrued Liabilities +5.7% -28.3%
Current Portion of Long Term Debt -100.0%
Other Current Liabilities +19.6% -38.1%
Total Current Liabilities -54.4% +0.1%
Operating Lease Liabilities Noncurrent -8.2% -44.5%
Other Noncurrent Liabilities +19.6% -38.1%
Total Liabilities -25.6% -5.3%
Equity
Preferred Stock
Common Stock +0.0% +0.0%
Additional Paid In Capital -0.8% +0.5%
Retained Earnings -8.2% -7.4%
Treasury Stock -1.7% -1.5%
Accumulated Other Comprehensive Income +6.4% -12.8%
Noncontrolling Interest -145.0% -9.1%
Total Stockholders Equity -12.0% -17.1%
Total Liabilitiesand Equity -22.2% -8.8%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 3 years
Ratio 2025 2024 2023
Profitability
Gross margin +30.1% +37.5% +40.1%
Operating margin -2.7% +0.1% +6.8%
Net margin -8.5% -6.1% +25.6%
FCF margin
Growth
Revenue CAGR (3y) +3.8% -4.3% -3.9%
Returns
ROE -15.6% -9.3% +31.6%
ROA -4.8% -2.5% +9.4%
ROIC -7.4% +0.2%
Liquidity
Current ratio 2.31x 1.36x 1.48x
Quick ratio 1.29x 0.53x 0.89x
Leverage
D/E 2.28x 2.69x 2.36x
Interest coverage -1.06x 0.03x 1.39x
Efficiency
Asset turnover 0.56x 0.41x 0.37x
Cash conversion cycle +118d +117d +188d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds BAX to your watchlist.